YWHAZ and nonpapillary renal cell carcinoma: Zhang et al. reported that miR-375 plays a tumor-suppressive role in ccRCC through the regulation of YWHAZ, highlighting its potential as an underlying therapeutic target in the treatment of patients with ccRCC [17].